Importance of Optimizing Duration of Adjuvant Immune Checkpoint Inhibitor Therapy to Treat Postoperative Hepatocellular Carcinoma after Conversion Therapy: a Case Report.
Journal of Surgical Case Reports（2023）
Key words
adjuvant,hepatocellular carcinoma,immune checkpoint inhibitor,treatment duration,tislelizumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined